Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea   Report issue

Academic/Hospital Phase 2
Founded: Santander Spain (1990)

Organization Overview

First Clinical Trial
2003
NCT02701517
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea